mounjaro patent expiration tirzepatide patent expiry In weight loss battle, Novo
Description
Tirzepatide has a lower rate of nausea and vomiting compared to Semaglutide, likely due to the presence of GIP, which helps mitigate gastrointestinal discomfort
Doucleff, M
Dispose of the pen after receiving 4 weekly doses
Appetite reduction is common
Modeled events included SAEs and treatment discontinuation
)
